TCT-29 Procedural and anatomic predictors of response in RADIANCE-HTN SOLO: a multicenter, randomized, sham-controlled trial of endovascular ultrasound renal denervation

The RADIANCE-HTN SOLO trial is the first randomized, blinded, sham-controlled study of endovascular ultrasound renal denervation (RDN) to treat hypertension in an off-medication population. Anatomic and procedural predictors of response to this therapy have not been described. Between March 2016